Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Head Neck. 2021 Sep 15;43(12):3788–3795. doi: 10.1002/hed.26865

Table 2.

Therapeutic approaches and outcomes in patients treated with curative intent (N = 10).

Treatment or outcome, No of patients (%) Data value

Induction chemotherapy 2 (20)
Radiation therapy 10 (100)
 Definitive RT 9 (90)
 Adjuvant RT 1 (10)
Definitive RT, median dose Gy (range) 72.0 (66.0–76.4)
Concomitant chemotherapy 7 (70)
 Cisplatin and etoposide 4 (57)
 Carboplatin and paclitaxel 1 (14)
 Cisplatin only 2 (28)
Surgery, No (%) 3 (30)
 Up-front surgery 1 (33)
 Salvage surgery 2 (67)

Best response to definitive (chemo)radiation
 CR 7 (78)
 PD 1 (11)
 Unknown 1 (11)
Recurrence 8 (80)
Median DFS (95% CI), mo 13.1 (8.53-NA)

CR, complete response; DFS, disease-free survival; PD, progressive disease.